Orphan designation: oregovomab Treatment of ovarian cancer, 30/07/2002 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 May 2026 - 12:06

Orphan designation: oregovomab Treatment of ovarian cancer, 30/07/2002 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-02-109

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters